PTJ
FPRX

Paul Tudor Jones’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Paul Tudor Jones’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,030
Closed -$94K – 1746
2020
Q3 		$94K Sell
20,030
-4,325
-18% -$22K ﹤0.01% 1189
2020
Q2 		$149K Sell
24,355
-36,794
-60% -$152K 0.01% 1059
2020
Q1 		$139K Sell
61,149
-29,455
-33% -$125K 0.01% 891
2019
Q4 		$416K Sell
90,604
-1,063
-1% -$4.21K 0.02% 777
2019
Q3 		$355K Buy
91,667
+1,800
+2% +$9.88K 0.01% 809
2019
Q2 		$542K Buy
+89,867
New +$859K 0.02% 689
2018
Q4 		– Sell
-16,199
Closed -$225K – 1308
2018
Q3 		$225K Buy
+16,199
New +$241K 0.01% 941
2018
Q1 		– Sell
-16,496
Closed -$362K – 1340
2017
Q4 		$362K Buy
16,496
+6,363
+63% +$205K 0.01% 738
2017
Q3 		$415K Sell
10,133
-1,866
-16% -$58.6K 0.01% 708
2017
Q2 		$361K Buy
11,999
+3,966
+49% +$124K 0.01% 693
2017
Q1 		$290K Buy
8,033
+2,910
+57% +$128K 0.01% 1023
2016
Q4 		$257K Sell
5,123
-1,477
-22% -$77.6K 0.01% 1090
2016
Q3 		$346K Sell
6,600
-5,700
-46% -$272K 0.01% 942
2016
Q2 		$509K Sell
12,300
-2,820
-19% -$123K 0.01% 822
2016
Q1 		$614K Buy
15,120
+2,035
+16% +$69.9K 0.02% 818
2015
Q4 		$543K Buy
13,085
+2,764
+27% +$92.7K 0.02% 811
2015
Q3 		$159K Buy
+10,321
New +$222K 0.01% 1381
2015
Q2 		– Sell
-10,228
Closed -$234K – 1740
2015
Q1 		$234K Buy
+10,228
New +$258K 0.01% 1205

Other funds holding FPRX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Paul Tudor Jones's FPRX Position: Q4 2020 in Review

Paul Tudor Jones sold out of Five Prime Therapeutics, Inc. (FPRX) in Q4 2020, closing a stake of 20,030 shares — an estimated $94K sold.

Paul Tudor Jones first reported a position in FPRX in Q1 2015 and held it in 18 quarters. The position peaked at $614K in Q1 2016. 125 funds tracked by Wall St. Rank hold FPRX as of Q4 2020.

  • Paul Tudor Jones reported no remaining Five Prime Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Paul Tudor Jones sold 20,030 Five Prime Therapeutics, Inc. shares in Q4 2020, an estimated $94K.
  • Paul Tudor Jones first reported a position in Five Prime Therapeutics, Inc. in Q1 2015 and held it in 18 quarters.
  • Paul Tudor Jones's Five Prime Therapeutics, Inc. position peaked at $614K in Q1 2016.
  • 125 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q4 2020.

Based on Tudor Investment Corp's 13F filing for Q4 2020, filed 16 Feb 2021.